Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocol
Published inRespiratory medicine and research, vol. 80, 100845
Publication date2021-11
Keywords
- Immunotherapy
- Metabolism
- Microbiota
- Non-small cell lung cancer
Affiliation
Research group
Citation (ISO format)
SANNICOLO, Sarah et al. Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocol. In: Respiratory medicine and research, 2021, vol. 80, p. 100845. doi: 10.1016/j.resmer.2021.100845
Identifiers
- PID : unige:159048
- DOI : 10.1016/j.resmer.2021.100845
- PMID : 34242975
ISSN of the journal2590-0412